Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats
Authors
Keywords
Diabetic nephropathy, Exenatide, Adipose-derived mesenchymal stem cell
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 892, Issue -, Pages 173721
Publisher
Elsevier BV
Online
2020-11-05
DOI
10.1016/j.ejphar.2020.173721
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adipose Tissue-Derived Mesenchymal Stem Cell Modulates the Immune Response of Allergic Rhinitis in a Rat Model
- (2019) Nesrine Ebrahim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal
- (2019) DIEGO A. DE MAGALHÃES et al. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
- An experimental study of exenatide effects on renal injury in diabetic rats
- (2019) Xiaodong Wang et al. Acta Cirurgica Brasileira
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incretins: Beyond type 2 diabetes
- (2018) Paresh Dandona et al. DIABETES OBESITY & METABOLISM
- Lixisenatide, a novel GLP-1 analog, protects against cerebral ischemia/reperfusion injury in diabetic rats
- (2018) Rania G. Abdel-latif et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Assessment of safety and feasibility of human allogeneic adipose-derived mesenchymal stem cells in a pediatric patient
- (2018) Atsuyuki Hirano et al. PEDIATRIC RESEARCH
- Mechanistic insights into the augmented effect of bone marrow mesenchymal stem cells and thiazolidinediones in streptozotocin-nicotinamide induced diabetic rats
- (2018) Alaaeldin Ahmed Hamza et al. Scientific Reports
- Mitochondrial Dysfunction in Diabetic Cardiomyopathy: Effect of Mesenchymal Stem Cell with PPAR-γ Agonist or Exendin-4
- (2017) Mohamed Wassef et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Modulation of heme oxygenase-1 expression and activity affects streptozotocin-induced diabetic nephropathy in rats
- (2017) Marwa A.M. Ali et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Diabetic nephropathy: Renoprotective effects of GLP1R agonists and SGLT2 inhibitors
- (2017) Berthold Hocher et al. Nature Reviews Nephrology
- GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
- (2017) Marcel H. A. Muskiet et al. Nature Reviews Nephrology
- Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal stem cell preserved renal function in a chronic kidney disease and sepsis syndrome setting in rats
- (2017) Chih-Hung Chen et al. Oncotarget
- New therapeutic agents in diabetic nephropathy
- (2017) Yaeni Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy
- (2016) Hong Lang et al. ARCHIVES OF MEDICAL RESEARCH
- The Cardiovascular Biology of Glucagon-like Peptide-1
- (2016) Daniel J. Drucker Cell Metabolism
- Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?
- (2016) Karly C. Sourris et al. CURRENT DRUG TARGETS
- Stromal cell–derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy
- (2016) Satoru Takashima et al. KIDNEY INTERNATIONAL
- Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy
- (2016) Amal H. Hamza et al. RENAL FAILURE
- Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
- (2016) Luigi Gnudi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Adipose Stem Cells Display Higher Regenerative Capacities and More Adaptable Electro-Kinetic Properties Compared to Bone Marrow-Derived Mesenchymal Stromal Cells
- (2016) Ahmed El-Badawy et al. Scientific Reports
- Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice
- (2015) Sander Kooijman et al. DIABETOLOGIA
- Adipose-Derived Mesenchymal Stem Cells Transplantation Alleviates Renal Injury in Streptozotocin-Induced Diabetic Nephropathy
- (2015) Weimin Ni et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro
- (2015) Hao Zhou et al. Scientific Reports
- Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus
- (2015) Fernando Ezquer et al. Biomed Research International
- Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress
- (2014) Shasha Lv et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats
- (2014) Amal Hofni et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Comparison of Nephron-protective Effects of Enalapril and GLP Analogues (Exenatide) in Diabetic Nephropathy
- (2014) T. Çavusoglu et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals
- (2014) Catarina Marques et al. MEDIATORS OF INFLAMMATION
- Liraglutide ameliorates renal injury in streptozotocin-induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor-κB pathway
- (2014) SAI-JUN ZHOU et al. Molecular Medicine Reports
- The role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy
- (2014) Mohamed Abdel Aziz et al. Diabetology & Metabolic Syndrome
- Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats
- (2013) Haojie Hao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sildenafil protects against nitric oxide deficiency-related nephrotoxicity in cyclosporine A treated rats
- (2013) Rania G. Abdel-latif et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting macrophage infiltration
- (2013) Sha-Sha Lv et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mechanism of the beneficial and protective effects of exenatide in diabetic rats
- (2013) Mohamed Lotfy et al. JOURNAL OF ENDOCRINOLOGY
- Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection
- (2013) D. Katagiri et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
- (2013) Hiroki Fujita et al. KIDNEY INTERNATIONAL
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
- (2012) Y. Si et al. DIABETES
- Exenatide Reduces Urinary Transforming Growth Factor-ß1 and Type IV Collagen Excretion in Patients with Type 2 Diabetes and Microalbuminuria
- (2012) Hong Zhang et al. KIDNEY & BLOOD PRESSURE RESEARCH
- GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases
- (2012) Hari Hendarto et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Glucagon-like peptide-1 inhibits angiotensin II-induced mesangial cell damage via protein kinase A
- (2012) Yuji Ishibashi et al. MICROVASCULAR RESEARCH
- The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy
- (2011) Matem Tunçdemir et al. ACTA HISTOCHEMICA
- Renal Function in Diabetic Disease Models: The Tubular System in the Pathophysiology of the Diabetic Kidney
- (2011) Volker Vallon et al. Annual Review of Physiology
- Albuminuria and Estimated Glomerular Filtration Rate as Predictors of Diabetic End-Stage Renal Disease and Death
- (2011) A. M. Berhane et al. Clinical Journal of the American Society of Nephrology
- Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
- (2011) R. Kodera et al. DIABETOLOGIA
- Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells
- (2011) Pan-Pan Chong et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Exenatide: clinical aspects of the first incretin-mimetic for the treatment of type 2 diabetes mellitus
- (2008) Estela Wajcberg et al. EXPERT OPINION ON PHARMACOTHERAPY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started